0001181431-14-032640.txt : 20140925
0001181431-14-032640.hdr.sgml : 20140925
20140925203448
ACCESSION NUMBER: 0001181431-14-032640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140924
FILED AS OF DATE: 20140925
DATE AS OF CHANGE: 20140925
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sagent Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001369786
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700
CITY: SCHAUMBURG
STATE: IL
ZIP: 60195
BUSINESS PHONE: 847-908-1604
MAIL ADDRESS:
STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700
CITY: SCHAUMBURG
STATE: IL
ZIP: 60195
FORMER COMPANY:
FORMER CONFORMED NAME: Sagent Holding Co.
DATE OF NAME CHANGE: 20090529
FORMER COMPANY:
FORMER CONFORMED NAME: NHS PHARMACEUTICALS
DATE OF NAME CHANGE: 20060720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FLANAGAN ROBERT J
CENTRAL INDEX KEY: 0001251512
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35144
FILM NUMBER: 141121744
MAIL ADDRESS:
STREET 1: C/O SAGENT PHARMACEUTICALS, INC.
STREET 2: 1901 NORTH ROSELLE ROAD, SUITE 700
CITY: SCHAUMBURG
STATE: IL
ZIP: 60195
4
1
rrd416690.xml
X0306
4
2014-09-24
0
0001369786
Sagent Pharmaceuticals, Inc.
SGNT
0001251512
FLANAGAN ROBERT J
C/O SAGENT PHARMACEUTICALS, INC.
1901 NORTH ROSELLE ROAD, SUITE 700
SCHAUMBURG
IL
60195
1
0
0
0
Common Stock
6996
D
Common Stock
2000
I
See Footnote
Common Stock
2014-09-24
4
S
0
8000
30.30
D
465770
I
See Footnote
Common Stock
2014-09-25
4
S
0
8000
29.72
D
457770
I
See Footnote
The shares reported are held by Flanagan Family Limited Partnership. Mr. Flanagan is a managing member of E.O. Flanagan LLC, the general partner of Flanagan Family Limited Partnership.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.89 to $30.52, inclusive. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2014.
The shares reported are held of record by CNF Investments II, LLC. Voting and investment decisions with respect to all shares held by CNF Investments II, LLC are exercised by its managing member, Mr. Flanagan. Accordingly, Mr. Flanagan may be deemed the beneficial owner of such shares.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.55 to $30.22, inclusive. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2014.
/s/ Robert J. Flanagan
2014-09-25